Kaken Pharmaceutical Co. Overview
Share Price
$53.53
(As of Thursday Closing)
Kaken Pharmaceutical Co. General Information
Description
Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Kaken Pharmaceutical Co. Stock Performance
(As of Tuesday closing)
| Stock Price |
Previous Close |
52 wk Range |
Market Cap |
Shares |
Average Volume |
EPS |
| $53.53 |
$54.93 |
$36.36 - $60.35 |
$2.09B |
39M |
218K |
$4.45 |
Kaken Pharmaceutical Co. Financials Summary
In Thousands,
USD
|
TTM
31-Dec-2019
|
FY 2019
31-Mar-2019
|
FY 2018
31-Mar-2018
|
FY 2017
31-Mar-2017
|
| EV |
1,590,326 |
1,372,480 |
2,020,443 |
2,065,188 |
| Revenue |
841,650 |
849,322 |
887,951 |
941,297 |
| EBITDA |
|
244,297 |
269,014 |
304,989 |
| Net Income |
175,024 |
160,318 |
171,786 |
203,200 |
| Total Assets |
1,474,331 |
1,406,798 |
1,434,244 |
1,207,977 |
| Total Debt |
35,584 |
34,948 |
36,464 |
34,658 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer